Emphysematous pyelonephritis successfully treated with nephrectomy and granulocyte colony-stimulating factor.
A 58-year-old woman developed diabetic ketoacidosis and emphysematous pyelonephritis caused by Escherichia coli. She was successfully treated with nephrectomy, antibiotics, and recombinant human granulocyte colony-stimulating factor (rhG-CSF). RhG-CSF therapy may be an effective adjunct for diabetic patients with severe infection, even when neutropenia is not present.
Nanki
T
T
Department of Internal Medicine, Tokyo Metropolitan Bokuto General Hospital.
Ageishi
Y
Y
Iwama
T
T
Murase
H
H
Uchikawa
T
T
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D016883:Diabetic Ketoacidosis / Q000150:complications*; D004646:Emphysema / Q000150:complications / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D004927:Escherichia coli Infections / Q000150:complications / Q000188:drug therapy / Q000601:surgery / Q000628:therapy; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D009392:Nephrectomy; D011704:Pyelonephritis / Q000150:complications / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor